CN Patent

CN108703950B — 一种罗拉吡坦的乳剂注射液

Assigned to Fubicheng Shanghai Pharmaceutical Technology Co ltd · Expires 2021-04-20 · 5y expired

What this patent protects

发明名称：一种罗拉吡坦乳剂注射液本发明涉及一种罗拉吡坦乳剂注射液，其包括罗拉吡坦、中链甘油三酯、大豆油、聚乙二醇15‑羟基硬脂酸酯、泊洛沙姆和注射用水，不包括油酸钠。本发明乳剂注射液与塑料输液容器用聚丙烯接口的包装材料相容性好，能有效减少对罗拉吡坦的吸附，且抑制包装材料中抗氧化剂等助剂向药液的迁移。

USPTO Abstract

发明名称：一种罗拉吡坦乳剂注射液本发明涉及一种罗拉吡坦乳剂注射液，其包括罗拉吡坦、中链甘油三酯、大豆油、聚乙二醇15‑羟基硬脂酸酯、泊洛沙姆和注射用水，不包括油酸钠。本发明乳剂注射液与塑料输液容器用聚丙烯接口的包装材料相容性好，能有效减少对罗拉吡坦的吸附，且抑制包装材料中抗氧化剂等助剂向药液的迁移。

Drugs covered by this patent

Patent Metadata

Patent number
CN108703950B
Jurisdiction
CN
Classification
—
Expires
2021-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Fubicheng Shanghai Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.